Retinitis Pigmentosa (RPE65) is a genetic condition that deteriorates the light-sensitive cells of the retina, causing progressive vision loss, night blindness, and can lead to complete blindness.
This Luxturna gene therapy holds the promise to stop or reverse this vision loss. Your contribution, no matter how small, can make a real difference in restoring Hossam's vision and giving hope for a brighter future.